Redwood City, CA · Founded 2015 · Privately Held (backing)
Developer of hydroxyl dendrimer therapeutics designed to meet the unmet medical needs in oncology, ophthalmology and inflammatory diseases. Ashvattha Therapeutics is based in Redwood City, CA and was founded in 2015. It was valued at $310 million at its later-stage round in Jan 2025, the last priced event on record. It has raised $217 million across 4 recorded rounds; the latest was a $60.2 million later-stage round in Apr 2021.
PMV mark · valuation
$310.0M
Oct 2026
Priced at
its later-stage round
Jan 2025
Total raised
$217.2M
Last round
Later Stage VC
Apr 2021
Cap table — not yet on record
Ashvattha Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Ashvattha Therapeutics with a free account
·The complete investor list: 37 names
·Watch Ashvattha Therapeutics: the Monday email on marks, rounds and moves
Where does Ashvattha Therapeutics's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Ashvattha Therapeutics's 4 recorded funding rounds.
